Camino de migas

Camino de migas

Estás en:

Publicador de contenidos

INFORME INAHTA

Informe completoAutologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis

Resumen: Autologous haematopoietic stem cell transplantation

Objetivo: Health Technology Wales undertook an evidence review to address the following question: is autologous haematopoietic stem cell transplantation (AHSCT) clinically and cost-effective for previously treated, relapsing-remitting multiple sclerosis (RRMS)?

Autoría: Health Technology Wales

Idioma: inglés

Fuente: INAHTA

Año de publicación: 2020